Cell Therapy DA01 Cleared for Phase 1 Trial in Advanced Disease Patients

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


https://parkinsonsnewstoday.com/2021/01/11/fda-clears-phase-1-trial-da01-bluerock-cell-therapy-advanced-parkinsons/

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.